EGFR and neoplasm: In addition to CCND1, rearrangements involving genes such as PIK3CA and EGFR are also implicated in OSCC pathophysiology, contributing to tumor progression and reduced therapeutic efficacy, thereby representing potential targets for novel treatment strategies [193].